US FDA May User Fee Preview: Vaccines, Gene Therapy, And Double Oncologics

RSV test
Moderna's RSV vaccine candidate has a 12 May user fee goal. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers